In another study, derived antigens as well as excretory/secretory products (ES) from adult Heligmosomoides polygyrus ( H
JNK, c-Jun N-terminal kinase
Promotes a soft, flexible, smooth, healthy, and radiant skin
Retatrutide Clinical Research Findings The clinical development program for retatrutide has produced compelling data across multiple research endpoints: Weight Loss Efficacy: Phase 2 trials showed dose-dependent weight reduction ranging from 8.7% at the lowest dose to 24.2% at the highest dose over 48 weeks Metabolic Improvements: Participants demonstrated improvements in glycemic control, lipid profiles, and blood pressure measurements Safety Profile: Gastrointestinal effects (nausea, vomiting, diarrhea) were the most common adverse events, occurring in 60-80% of participants but generally rated as mild to moderate in severity Sustained Effects: Weight loss continued throughout the trial period without evidence of plateau, suggesting ongoing metabolic benefits These findings have positioned retatrutide as a leading candidate for advanced metabolic research
Product info Composition Each 2ml ampoule contains: Nicotinamide (B3) - 100 mg B6 Pyridoxdine Hydrofloride (B6) - 100 mg Methyl Cobalamin B12 - 1000 mcg (Methyl Cobalamin) Directions for use As prescribed by your medical practitioner
